---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-074165"
form_type: "8-K"
ticker: "RLMD"
cik: "0001553643"
company_name: "RELMADA THERAPEUTICS, INC."
filed_at: "2023-09-06T23:59:59+00:00"
generated_at: "2026-06-10T23:23:03.206511+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Board member Eric Schmidt resigns; cites compliance for new sell-side analyst role

## Summary
- Eric Schmidt resigned from the Board effective September 5, 2023, with no disagreement with the company or management.
- Resignation due to compliance requirements from his new role as a sell-side equity analyst at a Wall Street investment banking firm.
- Schmidt served as a Class I director since 2019, chaired the Audit Committee, and was on the Governance Committee.
- No replacement has been announced for the vacant board position.

## SEC filing metadata
- accession: 0001213900-23-074165
- form_type: 8-K
- ticker: RLMD
- cik: 0001553643
- company_name: RELMADA THERAPEUTICS, INC.
- filed_at: 2023-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/0001213900-23-074165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/ea184757-8k_relmada.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-074165
- JSON: https://secwatch.observer/filing/0001213900-23-074165.json
- Plain text: https://secwatch.observer/filing/0001213900-23-074165.txt

## Key facts
- Executive change
  Eric Schmidt resigned as Member of the Board of Directors at RELMADA THERAPEUTICS, INC..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: On September 5, 2023, Eric Schmidt, a member of the Board of Directors (the “Board”) of Relmada Therapeutics, Inc. (the “Company”), notified the Company that he would resign from the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/0001213900-23-074165-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.